Invest along side VC’s and PE for access to high return startup flow. 
- Atlas’ $400M growth fund will support its portfolio of biotechs FirstWord Pharma
- Atlas Venture Announces $400 Million Third Opportunity Fund Business Wire
- VC Atlas lands $400M to support existing biotech portfolio Fierce Biotech
- Biotech VC raises $400 million ‘opportunity’ fund in sign of possible industry rebound statnews.com
- Atlas Venture reels in $400M to grow its biotech startups BioPharma Dive
